Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares
This study has been completed.
Information provided by (Responsible Party):
First received: January 24, 2008
Last updated: September 27, 2013
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2008|
|Primary Completion Date:||October 2008 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||November 23, 2010|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Schumacher HR Jr, Sundy JS, Terkeltaub R, Knapp HR, Mellis SJ, Stahl N, Yancopoulos GD, Soo Y, King-Davis S, Weinstein SP, Radin AR; 0619 Study Group.. Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012 Mar;64(3):876-84. doi: 10.1002/art.33412.